Genaissance Pharmaceuticals to Present at Rodman & Renshaw Techvest 2nd Annual Global Healthcare Conference

Genaissance Pharmaceuticals to Present at Rodman & Renshaw
Techvest 2nd Annual Global Healthcare Conference 


NEW HAVEN, Conn., April 27  /PRNewswire-FirstCall/ -- Genaissance
Pharmaceuticals, Inc. (NASDAQ:GNSC) today announced that Kevin Rakin, President
and Chief Executive Officer of Genaissance Pharmaceuticals, will present at the
Rodman & Renshaw Techvest 2nd Annual Global Healthcare Conference in Paris,
France, at 3:30 p.m. local time (9:30 a.m. Eastern) on Wednesday, May 4, 2005.

Mr. Rakin's remarks will also be available via a live webcast that can be
accessed through the Company's website: http://www.genaissance.com/.

Genaissance Pharmaceuticals, Inc. is developing innovative products based on
its proprietary pharmacogenomic technology and has a revenue-generating
business in DNA and pharmacogenomic products and services.  Genaissance also
markets its proprietary FAMILION(TM) Test, designed to detect mutations
responsible for causing Familial Long QT and Brugada Syndromes, two causes of
sudden cardiac death.  The Company's product development strategy is focused on
drug candidates with promising clinical profiles and finding genetic markers to
identify a responsive patient population.  This strategy is designed to enable
Genaissance to leverage existing clinical data and, thus, reduce the costs and
risks associated with traditional drug development and increase the probability
of clinical success and commercialization.  The Company's lead therapeutic
product, vilazodone for depression, is in Phase II of development.  For more
information on Genaissance, visit the Company's website at:
http://www.genaissance.com/. 

DATASOURCE: Genaissance Pharmaceuticals, Inc.



CONTACT:   Kevin Rakin, President & Chief Executive Officer, Genaissance

Pharmaceuticals, Inc., [phone]; or Rhonda Chiger (investors), Rx

Communications Group, [phone]; or Tom Redington (media), Redington,

Inc., [phone]



Web site:  http://www.genaissance.com/

Copyright